Close monitoring is required in the neonate affected by maternal Graves disease due to the potential for both central hypothyroidism and primary hyperthyroidism

J Paediatr Child Health. 2021 Sep;57(9):1516-1518. doi: 10.1111/jpc.15276. Epub 2020 Dec 10.

Authors

Farrah Rodrigues^{1

2}, Ken L Wan³, James Cg Doery^{3

4}, Zhong X Lu^{3

4}, Philip B Bergman^{1

2}, Jacqueline K Hewitt^{1

2}

Affiliations

¹ Department of Paediatric Endocrinology and Diabetes, Monash Children's Hospital, Melbourne, Victoria, Australia.
² Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
³ Department of Chemical Pathology, Monash Health Pathology, Monash Health, Melbourne, Victoria, Australia.
⁴ Department of Medicine, Monash University, Melbourne, Victoria, Australia.

PMID: 33301213
DOI: 10.1111/jpc.15276

No abstract available

Publication types

Case Reports

MeSH terms

Graves Disease* / diagnosis
Humans
Hyperthyroidism* / diagnosis
Hyperthyroidism* / etiology
Hypothyroidism* / diagnosis
Hypothyroidism* / etiology
Infant, Newborn